Solicited and Investigator-Initiated Research Project Grants

Within NIMHD’s three main extramural research interest areas—Clinical and Health Services Research, Integrative Biological and Behavioral Sciences, and Community Health and Population Sciences—the Institute supports a wide variety of solicited and investigator-initiated research projects grants (RPGs, e.g., R01, R21, R03, R15, R41/R42, R43/R44). Solicited research projects are funded under various Requests for Applications (RFAs), whereas investigator-initiated research projects are funded under NIH-wide “parent” Program Announcements (PAs), as well as PAs or PARs targeting specific scientific topics (see List of Programs below). All projects must focus on one or more health disparity populations, which include African Americans, Hispanics, American Indians, Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, rural populations, and sexual/gender minority groups.

NIMHD Program Announcements

• Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01/R21)
• Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01/R21)
• Addressing Health Disparities Through Effective Interventions Among Immigrant Populations (R01/R21)
• Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01 Clinical Trial Not Allowed)
• Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01 and R21 Clinical Trials Not Allowed)
• Health Services Research on Minority Health and Health Disparities (R01 and R21 Clinical Trial Optional)
• Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)
• Mechanisms and Consequences of Sleep Disparities in the U.S. (R01/R21)
• Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01/ R21)
• Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the United States: The Role of Risk and Protective Factors (R01/R21)
• Simulation Modeling and Systems Science to Address Health Disparities (R01 Clinical Trial Not Allowed)
• Social Epigenomics Research Focused on Minority Health and Health Disparities (R01/R21)
• Surgical Disparities Research (R01) and Exploratory/Developmental Surgical Disparities Research (R21)

NIMHD Requests for Applications

• Building Population Health Research Capacity in the U.S.-Affiliated Pacific Islands (U24)
• Community-based Participatory Research
• Innovations for Healthy Living—Improving Minority Health and Eliminating Health Disparities (R43/R44 Clinical Trial Optional)
• Mechanisms of Disparities for HIV-Related Comorbidities in Health Disparity Populations (R01 Clinical Trial Not Allowed)
• Minority Health and Health Disparities Research Training Program
• Prevention and Treatment Research to Address HIV/AIDS Disparities in Women in the US (R01 Clinical Trial Optional)
• Research on Pre-Exposure Prophylaxis (PrEP) to Prevent HIV in Health Disparity Populations (R01-Clinical Trial Not Allowed)
• Small Business Innovation Research/Small Business Technology Transfer Program
• Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42 Clinical Trial Optional)
• Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)